About
Technology
Issues
FAQ
Links
Official Page
Association Between Immune-Related Adverse Events and Recurrence-Free Survival Among Patients With Stage III Melanoma Randomized to Receive Pembrolizumab or Placebo
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.